Review Article

Arts Therapies for Anxiety, Depression, and Quality of Life in Breast Cancer Patients: A Systematic Review and Meta-Analysis

Table 2

GRADE assessment.

Quality assessmentNumber of patientsEffect Quality Importance
Number of studiesDesignRisk of biasInconsistencyIndirectnessImprecisionOther considerationsArt therapyControlRelative 
(95% CI)
Absolute

Anxiety (follow-up 0–28 weeks, assessed with STAI, HADS-anxiety)
4randomized trialsno serious risk of biasSome inconsistencyno serious indirectnessno serious imprecisionNone11788RR −7.09 
(−8.32 to −5.87)

MEDIUM
CRITICAL

Depression (follow-up 0–28 weeks, assessed with HADS, ZSDS, and CES-D)
3randomized trialsno serious risk of biasSome inconsistencyno serious indirectnessno serious imprecisionNone11788RR −1.05 
(−2.3 to 0.19)

MEDIUM
CRITICAL

Quality of life (follow-up 0–28 weeks, assessed with EORTC, FACTG)
3randomized trialsno serious risk of biasSome inconsistencyno serious indirectnessno serious imprecisionnone11788RR 1.89 
(−4.77 to 8.56)

MEDIUM
IMPORTANT